Raphas Co Ltd

XKRX:214260 (Korea (the Republic of))   Ordinary Shares
â‚© 13980.00 (+2.95%) Apr 30
At Loss
P/B:
4.06
Market Cap:
â‚© 119.86B ($ 86.41M)
Enterprise V:
â‚© 126.76B ($ 91.38M)
Volume:
23.21K
Avg Vol (2M):
33.38K
Volume:
23.21K
At Loss
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Raphas Co Ltd ( ) from 2019 to May 01 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Raphas stock (XKRX:214260) PE ratio as of May 01 2024 is 0. More Details

Raphas Co Ltd (XKRX:214260) PE Ratio (TTM) Chart

To

Raphas Co Ltd (XKRX:214260) PE Ratio (TTM) Historical Data

Total 1151
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 13
Raphas PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-01 At Loss 2024-02-26 At Loss
2024-04-30 At Loss 2024-02-23 At Loss
2024-04-29 At Loss 2024-02-22 At Loss
2024-04-26 At Loss 2024-02-21 At Loss
2024-04-25 At Loss 2024-02-20 At Loss
2024-04-24 At Loss 2024-02-19 At Loss
2024-04-23 At Loss 2024-02-16 At Loss
2024-04-22 At Loss 2024-02-15 At Loss
2024-04-19 At Loss 2024-02-14 At Loss
2024-04-18 At Loss 2024-02-13 At Loss
2024-04-17 At Loss 2024-02-08 At Loss
2024-04-16 At Loss 2024-02-07 At Loss
2024-04-15 At Loss 2024-02-06 At Loss
2024-04-12 At Loss 2024-02-05 At Loss
2024-04-11 At Loss 2024-02-02 At Loss
2024-04-09 At Loss 2024-02-01 At Loss
2024-04-08 At Loss 2024-01-31 At Loss
2024-04-05 At Loss 2024-01-30 At Loss
2024-04-04 At Loss 2024-01-29 At Loss
2024-04-03 At Loss 2024-01-26 At Loss
2024-04-02 At Loss 2024-01-25 At Loss
2024-04-01 At Loss 2024-01-24 At Loss
2024-03-29 At Loss 2024-01-23 At Loss
2024-03-28 At Loss 2024-01-22 At Loss
2024-03-27 At Loss 2024-01-19 At Loss
2024-03-26 At Loss 2024-01-18 At Loss
2024-03-25 At Loss 2024-01-17 At Loss
2024-03-22 At Loss 2024-01-16 At Loss
2024-03-21 At Loss 2024-01-15 At Loss
2024-03-20 At Loss 2024-01-12 At Loss
2024-03-19 At Loss 2024-01-11 At Loss
2024-03-18 At Loss 2024-01-10 At Loss
2024-03-15 At Loss 2024-01-09 At Loss
2024-03-14 At Loss 2024-01-08 At Loss
2024-03-13 At Loss 2024-01-05 At Loss
2024-03-12 At Loss 2024-01-04 At Loss
2024-03-11 At Loss 2024-01-03 At Loss
2024-03-08 At Loss 2024-01-02 At Loss
2024-03-07 At Loss 2023-12-28 At Loss
2024-03-06 At Loss 2023-12-27 At Loss
2024-03-05 At Loss 2023-12-26 At Loss
2024-03-04 At Loss 2023-12-22 At Loss
2024-02-29 At Loss 2023-12-21 At Loss
2024-02-28 At Loss 2023-12-20 At Loss
2024-02-27 At Loss 2023-12-19 At Loss

Raphas Co Ltd (XKRX:214260) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Raphas Co Ltd is engaged in the development of a drug delivery system. The company's products include Acropass, Cosmetics ODM, and Medical Contract Manufacturing Services. Its products are mostly used in biomedical products and all-natural cosmetic materials.